Skip to main content
SpringerLink
Log in

Gestational Diabetes

A Review of the Treatment Options

  • Review Article
  • Published:
Treatments in Endocrinology

Abstract

More than three decades since the original published description of gestational diabetes mellitus (GDM), no consensus exists regarding its implications or management. Targeting fetal macrosomia as the greatest morbidity, treatment strategies for this pregnancy-induced disease of insulin resistance have largely been modeled from therapies proven successful in pregnant women with type 2 diabetes mellitus. Surrounded by a rapidly expanding array of treatment options for insulin-resistant diabetes, potentially legitimate concerns about teratogenicity and fetal metabolic effects have limited clinical trials of insulin analogs and oral antihyperglycemic agents during pregnancy. So far, only insulin lispro and glyburide (glibenclamide) have been tested prospectively in randomized trials of women with GDM. In limited studies, both of these agents have compared favorably with standard insulin regimens, and neither appear to cause any fetal or neonatal harm. Although acknowledged by the American Diabetes Association (ADA) and the American College of Obstetricians and Gynecologists (ACOG), these seminal studies have not yet prompted a recommendation from either organization on how to utilize insulin analogs or oral antihyperglycemic agents in the treatment of GDM. Although they lack an evidence base for many therapeutic strategies for GDM, the current ADA and ACOG guidelines still provide a reasonable set of treatment recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II

Similar content being viewed by others

References

  1. American Diabetes Association. Position statement: gestational diabetes mellitus. Diabetes Care 2002; 25: S94–6

    Article  Google Scholar 

  2. Adams KM, Li H, Nelson RL, et al. Sequelae of unrecognized gestational diabetes. Am J Obstet Gynecol 1998; 178: 1321–3

    Article  PubMed  CAS  Google Scholar 

  3. Casey BM, Lucas MJ, Mclntire DD, et al. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997; 90: 869–73

    Article  PubMed  CAS  Google Scholar 

  4. Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 2001; 184: 77–83

    Article  PubMed  CAS  Google Scholar 

  5. Jensen DM, Damm P, Sorensen B, et al. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001; 185: 413–9

    Article  PubMed  CAS  Google Scholar 

  6. Innes KE, Byers TE, Marshall JA, et al. Association of a woman’s own birth weight with subsequent risk for gestational diabetes. JAMA 2002; 287: 2534–41

    Article  PubMed  Google Scholar 

  7. Cousins L, Rigg L, Hollingsworth D, et al. The 24-hour excursion and diurnal rhythm of glucose, insulin, and C-peptide in normal pregnancy. Am J Obstet Gynecol 1980; 136: 483–8

    PubMed  CAS  Google Scholar 

  8. Parretti E, Mecacci F, Papini M, et al. Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies. Diabetes Care 2001; 24: 1319–23

    Article  PubMed  CAS  Google Scholar 

  9. Homko C, Sivan E, Chen X, et al. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 2001; 86: 568–73

    Article  PubMed  CAS  Google Scholar 

  10. Xiang AH, Peters RK, Trigo E, et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes 1999; 48: 848–54

    Article  PubMed  CAS  Google Scholar 

  11. Jansson T, Ekstrand Y, Wennergren M, et al. Placental glucose transport in gestational diabetes mellitus. Am J Obstet Gynecol 2001; 184: 111–6

    Article  PubMed  CAS  Google Scholar 

  12. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999; 282: 1519–22

    Article  PubMed  CAS  Google Scholar 

  13. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195–200

    Article  PubMed  CAS  Google Scholar 

  14. American College of Obstetricians and Gynecologists. ACOG practice bulletin: gestational diabetes. Obstet Gynecol 2001; 98: 525–38

    Google Scholar 

  15. Perucchini D, Fischer U, Spinas GA, et al. Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. BMJ 1999; 319: 812–5

    Article  PubMed  CAS  Google Scholar 

  16. Lamar ME, Kuehl TJ, Cooney AT, et al. Jelly beans as an alternative to a fifty-gram glucose beverage for gestational diabetes screening. Am J Obstet Gynecol 1999; 181: 1154–7

    Article  PubMed  CAS  Google Scholar 

  17. Recommendations for the management of pregnant women with diabetes (including gestational diabetes): Diabetes UK [online]. Available from URL: http://www.diabetes.org.uk. [Accessed 2002 Jun 26]

  18. Young C, Kuehl TJ, Sulak PJ, et al. Gestational diabetes screening in subsequent pregnancies of previously healthy patients. Am J Obstet Gynecol 2000; 182: 1024–6

    Article  PubMed  CAS  Google Scholar 

  19. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1139–57

    Google Scholar 

  20. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768–73

    PubMed  CAS  Google Scholar 

  21. Pennison EH, Egerman RS. Perinatal outcomes in gestational diabetes: a comparison of criteria for diagnosis. Am J Obstet Gynecol 2001; 184: 1118–21

    Article  PubMed  CAS  Google Scholar 

  22. Goldberg JD, Franklin B, Lasser D, et al. Gestational diabetes: impact of home glucose monitoring on neonatal birth weight. Am J Obstet Gynecol 1986; 154: 546–50

    PubMed  CAS  Google Scholar 

  23. De Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333: 1237–41

    Article  PubMed  Google Scholar 

  24. Poyhonen-Alho M, Teramo K, Kaaja R. Treatment of gestational diabetes with short- or long-acting insulin and neonatal outcome: a pilot study. Acta Obstet Gynecol Scand 2002; 81: 258–9

    PubMed  Google Scholar 

  25. Major CA, Henry MJ, De Veciana M, et al. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet Gynecol 1998; 91: 600–4

    Article  PubMed  CAS  Google Scholar 

  26. Walkinshaw SA. Dietary regulation for ‘gestational diabetes’. In: Neilson JP, Crowther CA, Hodnett ED, et al., editors. Pregnancy and childbirth module of the cochrane database of systematic reviews. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 1997

    Google Scholar 

  27. Dornhorst A, Frost G. The principles of dietary management of gestational diabetes: reflection on current evidence. J Hum Nutr Diet 2002; 15: 145–56

    Article  PubMed  CAS  Google Scholar 

  28. Avery MD, Walker AJ. Acute effect of exercise on blood glucose and insulin levels in women with gestational diabetes. J Matern Fetal Med 2001; 10: 52–8

    Article  PubMed  CAS  Google Scholar 

  29. Avery MD, Leon AS, Kopher RA. Effects of a partially home-based exercise program for women with gestational diabetes. Obstet Gynecol 1997; 89: 10–5

    Article  PubMed  CAS  Google Scholar 

  30. Langer O, Levy J, Brustman L, et al. Glycemic control in gestational diabetes mellitus: how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989; 161: 646–53

    PubMed  CAS  Google Scholar 

  31. Langer O, Berkus M, Brustman L, et al. Rationale for insulin management in gestational diabetes mellitus. Diabetes 1991; 40Suppl. 2: 186–90

    PubMed  Google Scholar 

  32. Walkinshaw SA. Diet + insulin vs diet alone for gestational diabetes. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 1995

    Google Scholar 

  33. Heinemann L, Pfutzner A, Heise T. Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal, and pulmonary insulin delivery. Curr Pharm Des 2001; 7: 1327–51

    Article  PubMed  CAS  Google Scholar 

  34. Pieber TR, Eugene-Jolchine I, Derobert E, et al. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. Diabetes Care 2000; 23: 157–62

    Article  PubMed  CAS  Google Scholar 

  35. Ratner RE, Hirsch IB, Neifing JL, et al. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 2000; 23: 639–43

    Article  PubMed  CAS  Google Scholar 

  36. Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care 1999; 22: 1607–11

    Article  PubMed  CAS  Google Scholar 

  37. Murphy NP, Keane SM, Ong KK, et al. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens. Diabetes Care 2003; 26: 799–804

    Article  PubMed  CAS  Google Scholar 

  38. Rossetti P, Pampanelli S, Fanelli C, et al. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime. Diabetes Care 2003; 26: 1490–96

    Article  PubMed  CAS  Google Scholar 

  39. Yki-Jarvinen H, Dressier A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 study group. Diabetes Care 2000; 23: 1130–6

    Article  PubMed  CAS  Google Scholar 

  40. Brunelle RL, Llewelyn J, Anderson JH, et al. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998; 21: 1726–31

    Article  PubMed  CAS  Google Scholar 

  41. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999; 22: 1422–7

    Article  PubMed  CAS  Google Scholar 

  42. Persson B, Swahn ML, Hjertberg R, et al. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract 2002; 58: 115–21

    Article  PubMed  CAS  Google Scholar 

  43. Bhattacharyya A, Brown S, Hughes S, et al. Insulin lispro and regular insulin in pregnancy. Q J Med 2001; 94: 255–60

    Article  CAS  Google Scholar 

  44. Glazer NB, Zalani S, Anderson JH, et al. Safety of insulin lispro: pooled data from clinical trials. Am J Health Syst Pharm 1999; 56: 542–7

    PubMed  CAS  Google Scholar 

  45. Kurtzhals P, Schaffer L, Sorensen A, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000; 49: 999–1005

    Article  PubMed  CAS  Google Scholar 

  46. Reid TW, Reid WA. The labile nature of the insulin signal(s) for the stimulation of DNA synthesis in mouse lens epithelial and 3T3 cells. J Biol Chem 1987; 262: 229–33

    PubMed  CAS  Google Scholar 

  47. Scherbaum WA, Lankisch MR, Pawlowski B. Insulin lispro in pregnancy: retrospective analysis of 33 cases and matched controls. Exp Clin Endocrinol Diabetes 2002; 110(1): 6–9

    Article  PubMed  CAS  Google Scholar 

  48. Kitzmiller JL, Main E, Ward B, et al. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care 1999; 22: 874–6

    Article  PubMed  CAS  Google Scholar 

  49. Buchbinder A, Miodovnik M, McElvy S, et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000; 183: 1162–5

    Article  PubMed  CAS  Google Scholar 

  50. Loukovaara S, Immonen I, Teramo KA, et al. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro. Diabetes Care 2003; 26: 1193–8

    Article  PubMed  CAS  Google Scholar 

  51. US Food and Drug Administration. Pregnancy labeling. FDA Drug Bull 1979; 9: 23–4

    Google Scholar 

  52. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000; 17: 507–11

    Article  PubMed  CAS  Google Scholar 

  53. Zucker P, Simon G. Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy. Pediatrics 1968; 42: 824–5

    PubMed  CAS  Google Scholar 

  54. Piacquadio K, Hollingsworth DR, Murphy H. Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet 1991; 338: 866–9

    Article  PubMed  CAS  Google Scholar 

  55. Elliott BD, Schenker S, Langer O, et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994; 171(3): 653–60

    PubMed  CAS  Google Scholar 

  56. Elliott BD, Langer O, Schenker S, et al. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991; 165: 807–12

    PubMed  CAS  Google Scholar 

  57. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343: 1134–8

    Article  PubMed  CAS  Google Scholar 

  58. Elliott BD, Langer O, Schuessling F. Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin. Am J Obstet Gynecol 1997; 176: 527–30

    Article  PubMed  CAS  Google Scholar 

  59. Glueck CJ, Wang P, Kobayashi S. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 520–5

    Article  PubMed  CAS  Google Scholar 

  60. Zarate A, Ochoa R, Hernandez M, et al. Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy. Ginecol Obstet Mex 2000; 68: 42–5

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Scott & White Hospital and Clinic, Texas A&M University Health Science Center, 2401 S. 31st Street, Temple, Texas, 76508, USA

    Steven R. Allen

Authors
  1. Steven R. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven R. Allen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allen, S.R. Gestational Diabetes. Mol Diag Ther 2, 357–365 (2003). https://doi.org/10.2165/00024677-200302050-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00024677-200302050-00007

Keywords

Search

Navigation